The association between cholesterol efflux capacity and apolipoprotein A1: systematic review and meta-analysis.

Abstract

Introduction: High-density lipoprotein (HDL) particles are key participants in reverse cholesterol transport. Cholesterol efflux capacity (CEC) and apolipoprotein A1 (Apo A1) are HDL-related biomarkers often used to evaluate HDL particle functionality and quantity. This study aimed to assess the correlation between CEC and Apo A1 concentrations and explore whether methodological aspects influence the correlation results.

Materials and methods: This meta-analysis was prospectively registered in the PROSPERO database (registration number CRD42024552535). Three databases, PubMed, Web of Science, and Cochrane Library, were screened for the studies published between January 2000 and May 2024. The correlation results were analyzed using a random-effects model, and sensitivity and subgroup analyses were performed.

Results: A total of 19 studies with 4967 participants were included. This meta-analysis's results indicated a statistically significant positive moderate strength correlation between CEC and Apo A1 concentrations. A high level of study heterogeneity was observed among the included studies. Further exploration into this heterogeneity revealed that different cell culture lines and cholesterol acceptors used to evaluate CEC impact the overall result of the pooled correlation estimate. The methods used to evaluate Apo A1 did not significantly affect the correlation estimate between CEC and Apo A1 concentrations.

Conclusions: The correlation between CEC and Apo A1 lacks strength and consistency for Apo A1 being used as a surrogate marker for HDL function in a clinical setting. Currently, there is a high need for the standardization of CEC measurement methodologies that impact the overall results and comparability of the studies that have already been conducted.